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ABSTRAK ABSTRACT
Tujuan: Mengidentifikasi hubungan secara in vivo antara
25(OH)D dengan VEGF dalam kejadian preeklampsia berat.
Bahan dan Metode: Penelitian ini merupakan sebuah penelitian
analitik cross-sectional terhadap 36 wanita hamil, yang terdiri dari
18 pasien preeklampsia berat dan 18 pasien kontrol dengan usia
kehamilan yang sesuai. Pemeriksaan kadar 25(OH)D serum
dilakukan dengan chemiluminescent immunoassay (CLIA) dan
pemeriksaan VEGF serum dengan sandwich ELISA terhadap
semua pasien.
Hasil: Semua pasien sampel memiliki kadar 25(OH)D yang
termasuk dalam kelompok insufisiensi dan defisiensi. Baik
25(OH)D dan VEGF serum berhubungan secara signifikan dengan
kejadian preeklampsia berat dengan P masing-masing 0,012 dan
0,010. Tidak didapatkan hubungan bermakna antara kadar
25(OH)D serum dengan VEGF serum (P=0,629).
Simpulan: Kadar 25(OH)D yang rendah berhubungan dengan
peningkatan resiko terjadinya preeklampsia berat. Data yang ada
tidak mendukung hipotesis mengenai VEGF mediator hubungan
antara rendahnya kadar 25(OH)D serum dengan kejadian
preeklampsia berat.
Kata kunci: Vitamin D, 25-hydroxyvitamin D, vascular
endothelial growth factor, VEGF, preeklampsia berat
Objectives: To identify in vivo correlation between 25(OH)D and
VEGF in severe preeclampsia.
Materials and Methods: A case control, cross sectional study of
36 pregnant women which consist of 18 patients with preeclampsia
and 18 patients as control with gestational age-matched. We
perform 25(OH)D serum examination by chemiluminescent
immunoassay (CLIA) and VEGF serum examination by sandwich
ELISA to all patients.
Results: All patients are in 25(OH)D insufficiency and deficiency
state. Both maternal 25(OH)D and VEGF levels were inversely
associated with the risk of preeclampsia (both P<0.05). There is no
correlation between 25(OH)D serum level and VEGF serum level
(P=0,629).
Conclusion: Maternal vitamin D deficiency is associated with
increased preeclampsia risk. However, our data do not support the
hypothesis that the association between vitamin D deficiency and
preeclampsia is mediated by impaired level of VEGF.
Keywords: 25-hydroxyvitamin D, vascular endothelial growth
factor, preeclampsia
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INTRODUCTION
Preeclampsia is still a major cause of maternal morbid-
ity and mortality in the world. Data from WHO on 2012
mention as many as 10% of all pregnancy are compli-
cated with preeclampsia, with 5% of them need
intensive care for eclampsia and severe preeclampsia
complication. Almost 25% of babies born to preeclamp-
tic mother are IUGR.1
Vitamin D has been known to have a major role in
calcium metabolism, immune system, proliferation,
differentiation of cells, infection, and cancer.2 In the last
10 years, vitamin D has been studied to determine its
effect on conception, pregnancy and neonatal health.3
The maternal serum and umbilical cord level of
25(OH)D has been proven to penetrate the placenta and
fully meet the fetal needs of vitamin D.4 Levels of
25(OH)D in the serum is directly related to the intake of
vitamin D and sun exposure.5 Low level of 25(OH)D in
the first trimester of pregnancy is associated with the
incidence of preeclampsia.6 Furthermore, vitamin D
supplementation during the first year of life may reduce
the risk of preeclampsia by 50% in the first pregnancy.7
Magnus (2001) examined the incidence of preeclampsia
is associated with season. It was significantly lower in
the summer with high sun exposure and calcidiol levels
reached its peak.7
Vitamin D deficiency (levels of 25(OH)D<17.5 nmol/L)
and insufficiency (levels of 25(OH)D<50nmol/L)
apparently were found in tropical countries with
abundant sun exposure such as India and Bangladesh.
Green (2008) examined the levels of 25(OH)D in
women of reproductive age in Jakarta and Kuala
Lumpur, showed 60% of them having insufficient levels
of 25(OH)D.Many studies tried to unravel the patho-
genesis of preeclampsia associated with vitamin D
deficiency, for example in the inflammatory response
pathways, oxidative stress and angiogenesis. However,
Majalah Obstetri & Ginekologi, Vol. 23 No. 2 Mei - Agustus 2015 : 42-48
43
so far they have not obtained satisfactory results. One of
the factors of angiogenesis is vascular endothelial
growth factor (VEGF), considered able to be a predictor
factor for preeclampsia and even a therapeutic agent for
preeclampsia. Vitamin D is proven invitro to increase
the activity of VEGF as specific mitogen and prolifer-
ation of blood vessels.Our study aims to investigate the
relationship between 25(OH)D levels and serum VEGF
in pregnancy with preeclampsia, by comparing it with
low risk pregnancies. The results of this study are
expected to provide an overview of how the role of
25(OH)D in the pathogenesis of preeclampsia, and how
this relates to angiogenesis pathway.
MATERIALS AND METHODS
Subjects
Participating in this study were 36 pregnant women
which consist of 18 patients with preeclampsia and 18
patients as control with gestational age-matched.
Pregnant women were recruited consecutively into the
study during their visit at the antenatal clinics and
delivery room of Soetomo general hospital and
Soewandhi general hospital between November 2014
and February 2015. Women with a history of any
disease including chronic hypertension, obesity,
diabetes, liver disease, kidney failure, autoimmune,
twin pregnancy, and granulomatous diseases were
excluded. Participants were interviewed and a data form
was used to collect information about personal details,
age, gestational age, prepregnancy weight, parity,
education-al status, sun exposure duration, intake of
food contains vitamin D, and sunblock usage. Informed
consent was obtained and ethical approval was obtained
from Ethical board.
Serum 25(OH)D and VEGF measurement
We perform 25(OH)D serum examination by chemi-
luminescent immunoassay (CLIA) and VEGF serum
examination by sandwich ELISA to all patients. Cut-off
values for 25(OH)D were as follows: deficiency (less
than 10 ng/mL), insufficiency (10 to 30 ng/mL), and
normal (more than 30 ng/mL). Cut-off for VEGF values
were not available. Statistical analysis was carried out
using the IBM SPSS (Statistical Package for the Social
Sciences) statistical software package version 20.0. Data
were expressed as mean ± standard deviation (SD) or
number and percentage of subjects. Correlations were
performed using Spearman’s test. Comparisons were
conducted using unpaired Student’s two-tailed t-test
(Mann-Whitney as alternative). Chisquare tests
(Fisher’s test as alternative) were used to compare
categorical variables. In all tests, the level of signifi-
cance was P<0.05.
RESULTS AND DISCCUSION
In total, 36 subjects enrolled with 18 subjects each in
severe preeclapmsia and control group (Table 1). The
mean age of these subjects was 28.1 (SD 6.57) years.
There were one subject aged less than 18 years old and
six subjects aged more than 35 years old. Prepregnancy
BMI in severe preeclampsia and control group were
23.3 (SD 2.4) and 23.2 (SD 3.5), respectively. Most of
the subjects are having their first pregnancy. The
educational status were middle to high which means
most of the subjects at least have finished their high
school. We found no variables significantly influenced
the incidence of preeclampsia. The 25(OH)D levels in
severe preclapmsia and control group were 11.7 (SD
4.8) and 15.9 (SD 4.5) ng/mL, respectively. The VEGF
levels in preclapmsia and control group were 13.3 (SD
3.1) and 17.5 (SD 5.5) pg/mL, respectively. Both
maternal 25(OH)D and VEGF levels were inversely
associated with the risk of preeclampsia (both P<0.05).
Most of the subjects have 25(OH)D levels between 10
to 30 ng/mL (Table 2). Around 75% have insufficient
levels of 25(OH)D. There were no variables with the P
values less than 0.005. There were 20 out of 27 subjects
(74.1%) are at 28 weeks or more of gestational age
having insufficient levels of 25(OH)D compared to
66.6% subjects in the deficiency levels of 25(OH)D.
Most of the subjects are exposed to sunlight more than
90 minutes per day. More than 75% subjects in each
group taken at least twice per week of food that may
contains high level of vitamin D.
The overall mean of 25(OH)D levels was 13.9 (SD
5.06) ng/mL. There were a significant association as
shown (Table 3) between 25(OH)D levels and the inci-
dence of preeclampsia with OR 13.6 (P= 0.012, 95% CI
1.47  to 125.31).
Overall mean of VEGF levels was 15,4 (SD 4,89)
pg/mL. We also found a significant association between
VEGF levels and the incidence of preeclampsia (P=
0.010). But correlation analysis found out that there is
no correlation between 25(OH)D serum level and
VEGF serum level (P=0,629).
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Table 1. Subjects’ characteristics based on severe preeclampsia incidence
Variables
n(%)
Group
PSevere
preeclampsia Control
Age, mean(SD) [year] 29.2(6.9) 26.9(6.3) 0.305
Gestational age (n,%)
24-33 weeks 9 (50.0) 9(50.0) 1.000
>34 weeks 9 (50.0) 9(50.0)
Prepregnancy BMI,
mean(SD) 23.3(2.4) 23.2(3.5) 0.957
Parity (n,%)
Primigravida 11 (61.1) 10 (55.6) 0.735Multigravida 7 (38.9) 8 (44.4)
Educational status (n,%)
Low 9 (50.0) 1 (5.6)
0.057Middle 5 (27.8) 14(77.8)
High 4 (22.2) 3 (16.7)
Working (n,%)
Yes 8 (44.4) 12 (66.7) 0.180No 10 (55.6) 6 (33.3)
Hypertension history (n,%)
Yes 6(33.3) 5(27.8) 0.717No 11(66.7) 13(72.2)
Diabetes history (n,%)
Yes 1(5.6) 5(27.8) 0.177No 17(94.4) 13(72.2)
25(OH)D, mean(SD)
[ng/mL]
11.7(4.8) 15.9(4.5) 0.012*
VEGF, mean(SD)[pg/mL] 13.3(3.1) 17.5(5.5) 0.010*
*significant at P<0.05
Table 2. Subjects’ characteristics based on levels of 25(OH)D serum
Variables
n(%)
Levels of 25(OH)D serum
PDeficiency
N = 9
Insufficiency
N = 27
Age, mean(SD) 27.2(5.7) 28,3(6.9) 0.657
Gestational age (n,%) 9(25.0) 27(75.0)
24\-28 weeks 3(33.3) 7(25.9) 0.686
>28 weeks 6(66.6) 20(74.1)
Prepregnancy BMI,
mean(SD) 23,9(3.1) 23,1(2.9)
0.391
Parity (n,%)
Primigravida 5(55.6) 16(59.3) 1.000Multigravida 4(44.4) 11(40.7)
Educational status (n,%)
Low 4(44.4) 6(22.2)
0.893Middle 3(33.3) 16(59.3)
High 2(22.3) 5(18.5)
Working (n,%)
Yes 5(55.6) 15(55.6) 1.000No 4(44.4) 12(44.4)
Hypertension hist. (n,%)
Yes 4(44.4) 7(25.9) 0.409No 5(55.6) 20(74.1)
Diabetes history (n,%)
Yes 1(11.1) 5(18.5) 1.000No 8(88.9) 22(81.5)
Sun exposure(n,%)
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<90 min/day 2(22.2) 4(14.8) 0.627≥90 min/day 7(77.8) 23(85.2)
Vit D food intake (n,%)
Often 5(55.6) 15(55.6)
0.893Seldom 2(22.2) 12(44.4)
Never 2(22.2) 0(0.0)
Long sleeves (n,%)
Yes 3(33.3) 9(33.3) 1.000No 6(66.7) 18(66.7)
Sunblock usage
Yes 2(22.2) 3(11.1) 0.581No 7(77.8) 24(88.9)
Table 3. Association between incidence of severe preeclapmsia and 25(OH)D levels
25(OH)D
levels
Group, n(%)
OR P
CI
Severe
preeclampsia Control Lower Upper
Deficiency 8(44.4) 1(5.6)
13.6 0.012 1.47 125.31
Insufficiency 10(55.6) 17(94.4)
Our study did not found any variables that related to the
incidence of severe preeclampsia. Lechterman (2014)
reported the same results which mentioned that
mother’s age, prepregnancy BMI, gestational age, and
parity did not influenced the incidence of severe
preeclampsia. Most of our subjects having severe pre-
eclampsia are primigravida and low educational status.
Opitasari (2014) reported similar findings that parity
and educational status are factors influencing the
incidence of severe preeclampsia.8
Vitamin D deficiency and insufficiency
The present study showed a high  prevalence of vitamin
D deficiency and insufficiency among pregnant women
in Surabaya. About 25% have 25(OH)D levels lower
than 10 ng/mL and 75% have 25(OH)D levels between
10 to 30 ng/mL. None of them have normal 25(OH)D
levels. There were no variables found out to be signifi-
cantly influenced the incidence of deficiency or
insufficiency of 25(OH)D levels. Other study reported
by Lechterman at 2014 reported similiar results.
Vitamin D levels is influenced by adipose tissues. In
obese, vitamin D was stored in the fat cells that causing
a low 25(OH)D levels in serum.9 Therefore, in subjects
with obese or overweight, the 25(OH)D levels are
expected to dropped.10 In our study, there were no obese
women since its already excluded in the recruit-ment,
and 25% subjects are overweight. But there were no
significant association between BMI and 25(OH)D
levels in our study. This could be due to our small
sample and no subject have normal 25(OH)D levels.
Same results reported by Li (2011), who reported that
BMI was not associated with the levels of 25(OH)D
serum in pregnancy.
Skin colour was not included in our study since most of
our subject are Asians. De-Regil (2012) and Tsiaras
(2011) reported that skin colour influenced the levels of
vitamin D. They categorized the skin colour to African-
American, Caucasian, and Asian.10,11
Intake containing vitamin D especially in Asian,
contributed to 25(OH)D serum levels. Even though it is
not the main cause for vitamin D deficiency, some study
reported it influced the vitamin D status.12 In our study,
food intake was not significantly differs between
vitamin D deficiency and insufficiency. This could be
due to our data collection about the food intake did not
considered food with vitamin D fortification or the
concentration of vitamin D in those food. We only
collected the information about how many times subject
consumes food enriched with vitamin D.
Levels of 25(OH)D serum and severe
preeclampsia
Our study revealed the 25(OH)D serum was between
4.5 to 26.8 ng/mL. This findings are similar with other
studies especially in Asian. Sachan (2005) reported in
India 84% women with 25(OH)D serum levels lower
than 22.5 ng/mL. Cut-off values for 25(OH)D serum is
different among studies. Sachan used the cut-off level
for normal 25(OH)D is between 30 to 80 ng/mL. While
in Australia, the cut-off levels used are around 20
ng/mL. The low 25(OH)D levels in Asian women are
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suspected due to pigmentation and low intake of food
containing vitamin D.12 ,13
Levels of 25(OH)D is the gold standard for evaluating
vitamin D status. But since vitamin D metabolism in
complicated, the levels of 25(OH)D will give different
implication in every person. Therefore, it is suggested
that to know the vitamin D status, other parameters such
as parathyroid hormones are needed to checked also.
Parathyroid hormones usually will be lower when
25(OH)D lower than 20 ng/mL.14
There were a significant difference between preeclamp-
tic mother and control regarding the 25(OH)D levels
with P values lower than 0.05. This findings are also
supported by Xu (2014) with similar findings. Our study
reported that the 25(OH)D levels in preeclampsia  was
26% lower than in control group. This is greated than
previous studies reported by Xu (2014) around 14% and
Bodnar (2007) around 15%.  However, the mean levels
of vitamin D in this study is lower than those studies.
Mean of 21.76 ng/mL vs. 19.08 ng/mL at study Xu
(2014) and mean of 22.8 ng/mL vs. 19.6 ng/mL at study
Bodnar (2007). This is probably due to the sample of
this study was obtained from a variety of gestational age
with many different characteristics. Furthermore, our
research sampling conducted from November 2014 to
February 2015 in Surabaya, where rainfalls is very high
every day. It is said that differences in levels of
25(OH)D between preeclampsia patients and controls
obtained more significantly in the summer, when the
levels of 25(OH)D in normal pregnancy increased, but
remained lower in patients with preeclampsia.8
Recent studies have found that levels of 25(OH)D in
early pregnancy is lower in women who eventually
experienced preeclampsia. Decreased levels of 25(OH)
D to 20 ng/mL, gives a 2-fold increased risk of the
occurrence of preeclampsia.6 Research in Norway for
23,423 nulliparous women, found that vitamin D
supplementation as 10-15 μg/day is associated with a
27% reduction in the risk of preeclampsia compared
with no supplementation (OR=0.73, CI 0.58-0.92).15 In
this study, the odds ratio (OR) is 13.6. Since our study
did not have any subjects with normal value of
25(OH)D, we assumed that insufficiency were better
than deficiency. With this OR, it means that the
conditions of deficiency of 25(OH)D increase the risk of
severe preeclampsia at 13.6 times compared insufficien-
cy of 25(OH)D.
Levels of VEGF and severe preeclampsia
In this study, serum VEGF levels associated with the
incidence of severe preeclampsia (P = 0.010). These
results are similar to results of a study by Wang (2009)
which found a significant decrease in the levels of free
VEGF and PlGF serum preeclamptic patients compared
to normotensive patients and nonproteinuria using
sandwich ELISA examination technique. VEGF is
necessary to regulate blood pressure and maintain the
integrity of the glomerular filtration barrier. The inter-
action of VEGF with its receptors is essential for the
growth and function of the placenta, as well as
stabilization of the maternal blood vessels. Decrease in
the concentration of free VEGF in the serum of patients
preeclampsia causes endothelial cell dysfunction
maternal circulation. Polliotti et.al. showed that low
VEGF levels are predictors of preeclampsia in the
future. Levine et.al. found that levels of free VEGF in
patients with preeclampsia found to be lower than
normotensive women since 5 weeks prior to the occur-
rence of preeclampsia.16
In contrast, several studies such as Lyall (1997) and Oh
(2001) found an increase in total circulating VEGF in
serum of women with preeclampsia compared with
normotensive women, as well as research by Mc-
Keeman (2004) and Shaarawy (2005).16 The dis-
crepancy may occur due to the type of sandwich ELISA
cannot detect the levels of VEGF total (bound and free)
in serum. The study that found elevated levels of serum
VEGF preeclampsia are using radioimmunoassay or
ELISA system techniques that examine VEGF levels in
total, unlike our study.
Levels of 25(OH)D and levels of VEGF serum
Our study found that levels of 25(OH)D serum in
patients with preeclampsia and control is not associated
with serum VEGF levels (P = 0.629), although both
have a significant relationship with the occurrence of
preeclampsia. This may be due to the number of
samples is small (18 people for each group). Another
possibility is that each of the 25(OH)D and VEGF have
another pathophysiology in relation to the incidence of
severe preeclampsia.
It has been known that there are several biological
pathways for 25(OH)D in affecting the placenta, fetal,
maternal health and pregnancy growth. Vitamin D has a
role as an immunomodulator that is able to regulate the
immune response to the mother's placenta, and is able to
prevent infection during pregnancy.17 While in relation
to preeclampsia, vitamin D deficiency predisposes pro-
inflammatory response and increased oxidative stress
which ended with endothelial dysfunction. Increased
proinflammatory factors and oxidative stress may be an
important factor in the pathophysiology of preeclamp-
sia. Low levels of 25(OH)D are related to inflammatory
vascular endothelial cells, increased NFκB signaling in
suppressing vascular endothelial function, and reduced
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VDR on vascular endothelium and decreased expression
of 1-α hydroxylase. In addition, cells expressing pla-
cental trophoblast 1a-hydroxylase (CYP27B1) and VDR
in large numbers, so there is the hypothesis that vitamin
D has an important anti-inflammatory role of the
placenta.
Some studies also showed an increase in oxidative stress
in subjects with deficiency of vitamin D. This increase
can be reversed by vitamin D supplementation.18 In
2014, Wei conducted a study on the relationship of the
levels of 25(OH)D with increased oxidative stress
biomarkers and found that levels of 25(OH)D serum
biomarkers associated with increased levels of F2-
isoprostanes (5-iPF2a-VI) on gestational age 12 to 18
weeks (r = -0.261, P=0.01) and 24 to 26 weeks (r = -
0.246,P=0.02). After getting rid of confounding factors,
it was found that levels of 25(OH)D less than 50 nmol/L
at 24 to 26 weeks of gestation increased risk of pre-
eclampsia (OR 4.20, 95% CI 1.4 to 12.6).19
In this study, no relationship was found between
decreased levels of 25(OH)D serum with decreased
serum levels of VEGF. In this study, no assessment
levels of pro-inflammatory factors and biomarkers of
oxidative stress on the entire subject of research, so we
can not evaluate whether inflammatory or oxidative
stress factors that are more affected by reduced levels of
25(OH)D serum in the pathophysiology of preeclamp-
sia.
Studies on the role of VEGF in preeclampsia find some
mechanism reduction of VEGF. Several studies have
reported increased levels of antiangiogenesis factors
such as soluble fms-like tyrosine kinase (sFlt-1) is able
to reduce levels of free VEGF to below the critical point
needed for vasculogenesis and maintain vascularity
which has been formed during pregnancy.16 sFlt-1 is
expressed and secreted by several human tissues
including endometrial, endothelial cells, and placental
villus tissue. Several studies using primary cultures of
isolation of human cytotrophoblast cells showed that
low oxygen levels increased the expression of sFlt-1.
sFlt-1 binds to VEGF with high affinity, resulting in
lower levels of free VEGF. In normal pregnancy, levels
of sFlt-1 will increase with gestational age, but the
increase occurred more rapidly in serum and placental
tissue of preeclampsia patients. Increased expression of
sFlt-1 obtained in vitro and in vivo models with sFlt-1
by hypoxia conditions still can not be explained by
either. In this study, we did not examine  antiangio-
genesis factors such as sFlt-1, which may explain the
decrease in VEGF in our study.
CONCLUSION
Maternal vitamin D deficiency is associated with
increased preeclampsia risk. However, our data do not
support the hypothesis that the association between
vitamin D deficiency and preeclampsia is mediated by
impaired level of VEGF, although there were significant
differences of VEGF levels in preeclamptic mother to
normotensive mother. Further research are needed to
evaluate this phenomenon.
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